Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates;Çok İlaca Dirençli Tüberküloz İzolatlarinda Yaygin İlaç Direncinin Araştirilmasi

Mikrobiyoloji Bulteni

Volumn 47, Issue 1, 2013, Pages 59-70

  Bektöre, Bayhan ^a   Haznedaroǧlu, Tunçer ^a   Baylan, Orhan ^a   Özyurt, Mustafa ^a   Özkütük, Nuri ^b   Şatana, Dilek ^c   Çavuşoǧlu, Cengiz ^d   Seber, Engin ^e  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^e Istanbul Union Against Tuberculosis   (Turkey)

Author keywords

Extensively drug resistant tuberculosis; Multidrug resistant tuberculosis; Mycobacterium tuberculosis complex; Second line anti tuberculosis drug resistance

Indexed keywords

TUBERCULOSTATIC AGENT;

DRUG EFFECTS; DRUG RESISTANCE; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMAN; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84874385356     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: 10.5578/mb.4229     Document Type: Article

References (29)

1. Kiliçaslan Z. Dünyada ve Türkiye'de tuberküloz. Ankem 2007; 21 ( Ek 2): 76-80.
2. Baylan O. Çok Haca dirençli tüberkülozdan sonra yaygin ilaca dirençli ve tüm ilaçlara dirençli tüberküloz formlari: Eski hastaliǧin yeni yüzleri. Mikrobiyol Bul 2011; 45( 1): 181-95.
3. Baylan O. Ilaca dirençli tüberkülozun tedavisi. Turkiye Klinikleri J Med Sci 2012; 32( 3): 788-804.
4. World Health Organization. Global Tuberculosis Control: World Health Organization Report 2010. WHO/HTM/TB/ 2010. 7 . WHO, Geneva.
5. World Health Organization. Multidrug and Extensively Drug-Resistant Tuberculosis (M/XDR-TB): 2010 Global Report on Surveillance and Responce. WHO/HTM/TB/2010.3. WHO, Geneva.
6. Avkan Oǧuz V, Akbal H, Sanbaş S, Karagöz T, Öztürk R. Edinsel çok ilaca dirençli Mycobacterium tuberculosis suşlarinin major ve minör antitüberküloz ilaçlara duyarliliǧi. Infeksiyon Derg 2000; 14( 3): 383-6.
7. nd ed. CLSI, Wayne, PA.
8. T.C. Saǧlik Bakanliǧi Verem Savaşi Dairesi Başkanliǧi . Türkiye'de Verem Savaşi 2011 Raporu. Saǧlik Bakanliǧi Yayin No: 845, 2011. Fersa Ofset, Ankara.
9. Tansel Ö, Yüksel P, Kuloǧlu F, Akata F. Çok ilaca dirençli Mycobacterium tuberculosis suşlarinin sekonder antitüberküloz ilaçlara duyarlilik sonuçlan. Infeksiyon Derg 2003; 17( 3): 313-5.
10. Özkütük N, Sürücüoǧlu S, Gazi H, Coşkun M, Özkütük A, Özbakkaloǧlu B. Second-line drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis isolates in Aegean region-Turkey. Turk J Med Sci 2008; 38(3): 245-50. (Pubitemid 351872823)
11. Uzun M, Kiraz M, Kaya D, Aktan G, Kasimoǧlu Ö. Mycobacterium türierinin antitüberküloz ilaçlara duyarliliklari. Ankem 1993; 7( 4): 273-6.
12. Yüce A, Yücesoy M, Ercan H, Çeliktepe E, Yuluǧ N. Mycobacterium tuberculosis suşlarinin antitüberkülo ilaçlara direnç paternleri ve izoniazid direnci ile katalaz aktivitesi arasindaki ilişki. Klimik Derg 1997; 10( 1): 33-5.
13. Çiçek Saydam C, Çavuşoǧlu C, Burhanoǧlu D, Özkalay N, Badak FZ, Bilgiç A. Susceptibility of Mycobocterium tuberculosis strains to first-line and second-line anti-tuberculosis drugs in Ege University hospital. Turk J Med Sci 2001; 31(5): 395-400. (Pubitemid 32771930)
14. Toungoussova OS, Mariandyshev AO, Bjune G, Caugant DA, Sandven P. Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. Eur J Clin Microbiol Infect Dis 2005; 24(3): 202-6. (Pubitemid 40576667)
15. Ermertcan S, Hosgor-Limoncu M, Erac B, Tasli H, Cavusoglu C, Bozkurt H. In vitro activity of linezolid against Mycobacterium tuberculosis strains isolated from Western Turkey. Jpn J Infect Dis 2009; 62( 5): 384-5.
16. Mitchison DA. Drug resistance in tuberculosis. Eur Respir J 2005; 25(2): 376-9. (Pubitemid 40246541)
17. Springer B, Lucke K, Calligaris-Maibach R, Ritter C, Böttger EC. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J Clin Microbiol 2009; 47( 6): 1773-80.
18. Morcillo N, Di Giulio B, Testani B, Pontino M, Chirico C, Dolmann A. A microplate indicator-based method for determining the susceptibility of multidrug-resistant Mycobacterium tuberculosis to antimicrobial agents. Int J Tuberc Lung Dis 2004; 8(2): 253-9. (Pubitemid 38622935)
19. Kayali R, Cöplü N, Ceyhan I, Ocak F, Citil BE, Esen B. The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains. Mikrobiyol Bul 2006; 40( 1-2): 1-7.
20. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995; 8( 4): 496-514.
21. Catana D, Yeǧenoǧlu Y. Çoǧul ilaca dirençli Mycobacterium tuberculosis kompleksi suşlarinin sekonder ilaçlara duyarliliǧinin BACTEC ve agar proporsiyon yöntemleri ile arastirilmasi, s: 198. Uzun M, Erturan Z (ed), 4. Ulusal Mikobakteri Simpozyumu (31 Ekim-2 Kasim 2002, Abant) Kitabi. 2002, Turk Mikrobiyoloji Cemiyeti Yaym No: 45, Istanbul.
22. Abate G, Miorner H, Ahmed O, Hoffner SE. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs. Int J Tuberc Lung Dis 1998; 2(7): 580-4. (Pubitemid 28320067)
23. Di Perri G, Bonora S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis? J Antimicrob Chemother 2004; 54(3): 593-602. (Pubitemid 39263899)
24. Sürücüoǧlu S, Akçali S, Kurutepe S, Saydam C, Özkütük N, Özbakkaloǧlu B. Mycobacterium tuberculosis izolatlarinin levofloksasine in vitro duyarliliǧi. Infeksiyon Derg 2000; 14( 2): 197-200.
25. Richter E, Rüsch-Gerdes S, Hillemann D. First linezolid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51(4): 1534-6. (Pubitemid 46586846)
26. Huang TS, Liu YC, Chen YS, Tu HZ, Chen BC. In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrob Agents Chemother 2008; 52( 6): 2226-7.
27. Schecter GF, Scott C, True L, Raftery A, Flood J, Mase S. Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis 2010; 50( 1): 49-55.
28. Erturan Z, Uzun M. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates. Int J Antimicrob Agents 2005; 26(1): 78-80. (Pubitemid 40854121)
29. Ökten F, Ertürk A, Mutlu A, Çalişir H, Yener O, Öǧretensoy M. Mycobacterium tuberculosis' in streptomisin, kanamisin ve amikasine karşi in vitro duyarliliǧi ve bu ilaçlar arasindaki çapraz direnç ilişkisi. Tuberk Toraks 2002; 50( 1): 44-7.